Exchange: OTC·Updated 11:53 AM EDT

NGHLF Nightingale Health Oyj - Ordinary Shares - Series B

$1.19
$0.15
(11.19%)
Today
Mkt Cap$71.83M
Vol100.00

About NGHLF

Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. Its blood analysis technology utilizes nuclear magnetic resonance and proprietary software to provide health data that links a person's lifestyle to disease risk. The company was founded by Antti Juhana Kangas, Juha Pekka Pöysä, Satu Saksman, Pasi Soininen, Teemu Pentti Suna, and Peter Würtz in 2002 and is headquartered in Helsinki, Finland.
50

Neutral Sentiment

How do you feel about NGHLF?

Advertisement|Remove ads.